Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-25-000592
Filing Date
2025-09-08
Accepted
2025-09-08 17:44:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11378
2 AGREEMENT RE JOINT FILING stonepineex99.htm EX-99 4492
  Complete submission text file 0000935836-25-000592.txt   17597
Mailing Address 2900 NW CLEARWATER DRIVE SUITE 100-11 BEND OR 97703
Business Address 2900 NW CLEARWATER DRIVE SUITE 100-11 BEND OR 97703 541-647-5673
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Subject) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90539 | Film No.: 251301085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)